PTC THERAPEUTICS, INC. ($PTCT)
Filing Information
| Accession Number | 0001578852-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
66,298
Total Value
$260,517.70
P&L
+inf% (+$3,992,450.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EXEC. VP AND CLO | Common Stock | โ | Jan 2, 2026 | Grant/Award | 17,000 | $0.00 | $0.00 | 120,901 | Direct | โ | View Details | |
EXEC. VP AND CLO | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 2,266 | $39.42 | $89,325.72 | 123,167 | Direct | โ | View Details | |
EXEC. VP AND CLO | Common Stock | โ | Jan 5, 2026 | Sale | 1,123 | $74.92 | $84,135.16 | 122,044 | Direct | โ | View Details | |
EXEC. VP AND CLO | Common Stock | โ | Jan 5, 2026 | Sale | 1,035 | $76.10 | $78,763.50 | 121,009 | Direct | โ | View Details | |
EXEC. VP AND CLO | Common Stock | โ | Jan 5, 2026 | Sale | 108 | $76.79 | $8,293.32 | 120,901 | Direct | โ | View Details | |
EXEC. VP AND CLO | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Grant/Award | 42,500 | $0.00 | $0.00 | 42,500 | Direct | โ | View Details | |
EXEC. VP AND CLO | Stock Option (Right to Buy) | Derivative | Jan 5, 2026 | Exercise/Conversion | 2,266 | $0.00 | $0.00 | 9,063 | Direct | โ | View Details |